Genetic inhibition of caspase-2 reduces hypoxic-ischemic and excitotoxic neonatal brain injury

Annals of Neurology

Volumn 70, Issue 5, 2011, Pages 781-789

  Carlsson, Ylva ^a,b   Schwendimann, Leslie ^c,d   Vontell, Regina ^e   Rousset, Catherine I ^a,e   Wang, Xiaoyang ^a   Lebon, Sophie ^c,d   Charriaut Marlangue, Christiane ^c,d   Supramaniam, Veena ^e   Hagberg, Henrik ^a,b,e   Gressens, Pierre ^c,d,e,f   Jacotot, Etienne ^a,c,d,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Centre for the Developing Brain   (United Kingdom)

^f HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 3; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; EXCITOTOXICITY; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS; WESTERN BLOTTING; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CASPASE 2; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; IBOTENIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROTOXINS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, SMALL INTERFERING;

EID: 80053392102     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22431     Document Type: Article

References (46)

1. du Plessis AJ, Volpe JJ,. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002; 15: 151-157.
2. Ferriero DM,. Neonatal brain injury. N Engl J Med 2004; 351: 1985-1995.
3. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361: 1349-1358.
4. Gonzalez FF, Ferriero DM,. Neuroprotection in the newborn infant. Clin Perinatol 2009; 36: 859-880.
5. Northington FJ, Zelaya ME, O'Riordan DP, et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 2007; 149: 822-833.
6. Kaindl AM, Favrais G, Gressens P,. Molecular mechanisms involved in injury to the preterm brain. J Child Neurol 2009; 24: 1112-1118.
7. Hagberg H, Mallard C, Rousset CI, Wang X,. Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol 2009; 24: 1141-1146.
8. Wang X, Carlsson Y, Basso E, et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci 2009; 29: 2588-2596.
9. Wang X, Han W, Du X, et al. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 2010; 41: 2050-2055.
10. Thornberry NA, Lazebnik Y,. Caspases: enemies within. Science 1998; 281: 1312-1316.
11. Kumar S, Kinoshita M, Noda M, et al. Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 1994; 8: 1613-1626.
12. Madesh M, Zong WX, Hawkins BJ, et al. Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak. Mol Cell Biol 2009; 29: 3099-3112.
13. Tiwari M, Lopez-Cruzan M, Morgan WW, Herman B,. Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons. J Biol Chem 2011; 286: 8493-8506.
14. Kumar S,. Caspase-2 in apoptosis, the DNA damage response and tumor suppression: enigma no more? Nat Rev Cancer 2009; 9: 897-903.
15. Bouchier-Hayes L,. The role of caspase-2 in stress-induced apoptosis. J Cell Mol Med 2010; 14: 1212-1224.
16. Vakifahmetoglu-Norberg H, Zhivotovsky B,. The unpredictable caspase-2: what can it do? Trends Cell Biol 2010; 20: 150-159.
17. Tinel A, Tschopp J,. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846.
18. Bouchier-Hayes L, Oberst A, McStay GP, et al. Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol Cell 2009; 35: 830-840.
19. Troy CM, Stefanis L, Greene LA, Shelanski ML,. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J Neurosci 1997; 17: 1911-1918.
20. Troy CM, Rabacchi SA, Hohl JB, et al. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 2001; 21: 5007-5016.
21. Bergeron L, Perez GI, Macdonald G, et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304-1314.
22. Niizuma K, Endo H, Nito C, et al. The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats. Proc Natl Acad Sci U S A 2008; 105: 16368-16373.
23. Rice JE III, Vannucci RC, Brierley JB,. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981; 9: 131-141.
24. Medja F, Lelievre V, Fontaine RH, et al. Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice. Brain 2006; 129: 3209-3223.
25. Jackson AL, Burchard J, Leake D, et al. Position-specific chemical modification of siRNA reduce off-target transcript silencing. RNA 2006; 12: 1197-1205.
26. Zhu C, Wang X, Xu F, et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005; 12: 162-176.
27. Northington FJ, Ferriero DM, Martin LJ,. Neurodegeneration in the thalamus following neonatal hypoxia-ischemia is programmed cell death. Dev Neurosci 2001; 23: 186-191.
28. Northington FJ, Ferriero DM, Flock DL, Martin LJ,. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001; 21: 1931-1938.
29. Johnston M,. Excitotoxicity in perinatal brain injury. Brain Pathol 2005; 15: 234-240.
30. Marret S, Mukendi R, Gadisseux JF, et al. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 1995; 54: 358-370.
31. Whither RNAi? Nat Cell Biol 2003; 5: 489-490.
32. Cullen BR,. Enhancing and confirming the specificity of RNAi experiments. Nat Methods 2006; 3: 677-681.
33. Chauvier D, Lecoeur H, Langonne A, et al. Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Apoptosis 2005; 10: 1243-1259.
34. Hu BR, Liu CL, Ouyang Y, et al. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000; 20: 1294-1300.
35. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992-1999.
36. Han BH, Xu D, Choi J, et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 2002; 277: 30128-30136.
37. West T, Atzeva M, Holtzman DM,. Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiol Dis 2006; 22: 523-537.
38. Joly LM, Mucignat V, Mariani J, et al. Caspase inhibition after neonatal ischemia in the rat brain. J Cereb Blood Flow Metab 2004; 24: 124-131.
39. Zhu C, Qiu L, Wang X, et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003; 86: 306-317.
40. Puyal J, Vaslin A, Mottier V, Clarke PG,. Postischemic treatment of neonatal cerebral ischemia should target autophagy. Ann Neurol 2009; 66: 378-389.
41. Karatas H, Aktas Y, Gursoy-Ozdemir Y, et al. A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci 2009; 29: 13761-13769.
42. Lu C, Fu W, Salvesen GS, Mattson MP,. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med 2002; 1: 69-79.
43. Gulyaeva NV,. Non-apoptotic functions of caspase-3 in nervous tissue. Biochemistry (Mosc) 2003; 68: 1171-1180.
44. Li Z, Jo J, Jia JM, et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010; 141: 859-871.
45. Kuida K, Zheng TS, Na S, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384: 368-372.
46. Kuida K, Haydar TF, Kuan CY, et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998; 94: 325-337.